Category: Include on Menu
-
Rexford Industrial Realty shares surge after Elliott stake disclosure
Rexford Industrial Realty (NYSE:REXR) shares climbed more than 5% on Wednesday following a Bloomberg report indicating that activist investor Elliott Investment Management has acquired a significant stake in the Los Angeles-based real estate investment trust. Sources familiar with the situation said that Elliott’s holding positions it among Rexford’s top five shareholders, although the hedge fund’s…
-
Greenwave shares dip after receiving another Nasdaq delinquency notice
Greenwave Technology Solutions Inc (NASDAQ:GWAV) stock fell 2.3% in Wednesday premarket trading after the metal recycling firm received an additional delinquency notice from Nasdaq for not submitting required financial reports on time. The company disclosed that it received this notice on August 22, 2025, regarding its delay in filing the Quarterly Report on Form 10-Q…
-
Azitra shares surge after first patient receives ATR04-484 in Phase 1/2 trial
Azitra Inc (AMEX:AZTR) stock jumped 67% in premarket trading Wednesday following the announcement that the first patient has been dosed in the Phase 1/2 trial for ATR04-484, a potential treatment for EGFR inhibitor-associated rash. The candidate, a topical live biotherapeutic, aims to treat a condition affecting roughly 150,000 people annually in the U.S. It has…
-
BeOne Medicines shares dip after EU greenlights TEVIMBRA for lung cancer
BeOne Medicines AG (NASDAQ:ONC) stock fell 3.2% following the European Commission’s approval of TEVIMBRA (tislelizumab) for treating resectable non-small cell lung cancer (NSCLC) at high risk of recurrence. The approval stems from the Phase 3 RATIONALE-315 trial, which showed that TEVIMBRA combined with platinum-based chemotherapy before surgery, followed by TEVIMBRA monotherapy, provided a statistically significant…
-
Vor Biopharma shares rise after collaborator’s IgAN therapy meets Phase 3 endpoint
Vor Biopharma Inc (NASDAQ:VOR) saw its stock climb 2.9% following news that its partner RemeGen Co., Ltd (USOTC:REGMY) successfully hit the primary endpoint in Stage A of a Phase 3 trial for telitacicept in adults with IgA nephropathy (IgAN). The China-based study reported a 55% reduction in 24-hour urine protein-to-creatinine ratio (UPCR) at 39 weeks…
-
Williams-Sonoma beats Q2 forecasts, lifts revenue guidance
Williams-Sonoma, Inc. (NYSE:WSM) surpassed analyst expectations for its second-quarter results, reporting adjusted earnings per share of $2.00, above the consensus estimate of $1.78. Quarterly revenue reached $1.84 billion, exceeding forecasts of $1.82 billion. The home goods retailer achieved comparable brand revenue growth of 3.7% year-over-year, with all brands posting positive comparable sales. Its operating margin…
-
DevvStream shares surge after regaining Nasdaq compliance
DevvStream Corp. (NASDAQ:DEVS) saw its stock jump 31.6% in premarket trading Wednesday following news that the carbon management company has restored compliance with Nasdaq’s minimum bid price rule. The firm received notification from Nasdaq on August 22, 2025, confirming it met the exchange’s listing standards. Previously, DevvStream’s shares had traded below the $1.00 minimum bid…
-
AgriFORCE shares jump after 4 MW mining deal in Alberta
AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) saw its stock surge 12.1% in premarket trading Wednesday following the announcement of a definitive agreement with BlueFlare Energy Solutions to deploy a 4 MW mining infrastructure in Alberta, Canada. This deal, building on a previously announced binding Letter of Intent, is expected to provide roughly 250 Ph/s of hash…
-
Shineco shares jump following blockchain alliance with BICC
Shares of Shineco Inc. (NASDAQ:SISI) climbed 6.1% in premarket trading Wednesday after the company announced a strategic partnership with Singapore-based BICC Pte Ltd to jointly promote “on-chain cell assets” across multiple institutions and use cases. The agreement is designed to advance the real-world asset (RWA) ecosystem, moving from technical integration to practical deployment, and to…
-
BofA: Intel unlikely to spin off or sell foundry business in next five years
Recent capital infusions into Intel (NASDAQ:INTC) have strengthened the company’s balance sheet, but they also make a near-term sale or spin-off of its foundry operations improbable, according to Bank of America analysts. Intel recently secured $2 billion in equity from SoftBank at $23 per share and $8.9 billion from the U.S. government, representing a 9.9%…